section name header

Pronunciation

GLI-ser-in audio

Classifications

Therapeutic Classification: antiglaucoma agents, laxatives

Pharmacologic Classification: osmotics

Indications

REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: Not significantly absorbed from colonic mucosa.

Distribution: Remains in the intravascular space.

Metabolism/Excretion: 80% metabolized by the liver, 10–20% metabolized by the kidneys.

Half-life: 30–45 min.

Time/Action Profile

ROUTEONSETPEAKDURATION
Rect (laxative effect)unknown15–30 minunknown
Ophth (reduced corneal swelling)unknownunknown3–4 hr

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CNS: confusion, headache.

GI: diarrhea, cramping, nausea, vomiting.

F and E: dehydration.

Misc: thirst.

Interactions

Drug-Drug:

Route/Dosage

Laxative

Reduction of Corneal Edema

Availability

(Generic available)

Assessment

Lab Test Considerations:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Fleet Babylax, Sani-Supp

Pot. Nursing Diagnoses

Code

NDC Code*